The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R

EuroIntervention 2017;13:1320-1327 published online June 2017. DOI: 10.4244/EIJ-D-17-00291

1. Department of Cardiology, Munich University Clinic, LMU, Munich, Germany; 2. German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany; 3. Department of Cardiology, Friedrich-Alexander University Erlangen-Nürnberg,

Aims: The aim of this study was to assess clinical restenosis and its predictors after implantation of bioresorbable vascular scaffolds (BVS) in everyday practice in the large-scale Germa

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Difference in haemodynamic microenvironment in vessels scaffolded with Absorb BVS and Mirage BRMS: insights from a preclinical endothelial shear stress study